7e5v
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of Phm7 in complex with inhibitor== | ==Crystal structure of Phm7 in complex with inhibitor== | ||
- | <StructureSection load='7e5v' size='340' side='right'caption='[[7e5v]]' scene=''> | + | <StructureSection load='7e5v' size='340' side='right'caption='[[7e5v]], [[Resolution|resolution]] 1.61Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7E5V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7E5V FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[7e5v]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Pyrsx Pyrsx]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7E5V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7E5V FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7e5v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7e5v OCA], [https://pdbe.org/7e5v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7e5v RCSB], [https://www.ebi.ac.uk/pdbsum/7e5v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7e5v ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=HZC:[(1S,2S,5R)-5-methyl-2-propan-2-yl-cyclohexyl]methanamine'>HZC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">phm7 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1756125 PYRSX])</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7e5v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7e5v OCA], [https://pdbe.org/7e5v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7e5v RCSB], [https://www.ebi.ac.uk/pdbsum/7e5v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7e5v ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Enzymes catalyzing [4+2] cycloaddition have attracted increasing attention because of their key roles in natural product biosynthesis. Here, we solved the X-ray crystal structures of a pair of decalin synthases, Fsa2 and Phm7, that catalyze intramolecular [4+2] cycloadditions to form enantiomeric decalin scaffolds during biosynthesis of the HIV-1 integrase inhibitor equisetin and its stereochemical opposite, phomasetin. Computational modeling, using molecular dynamics simulations as well as quantum chemical calculations, demonstrates that the reactions proceed through synergetic conformational constraints assuring transition state-like substrates folds and their stabilization by specific protein-substrate interactions. Site-directed mutagenesis experiments verified the binding models. Intriguingly, the flexibility of bound substrates is largely different in two enzymes, suggesting the distinctive mechanism of dynamics regulation behind these stereoselective reactions. The proposed reaction mechanism herein deepens the basic understanding how these enzymes work but also provides a guiding principle to create artificial enzymes. | ||
+ | |||
+ | Molecular basis for two stereoselective Diels-Alderases that produce decalin skeletons.,Fujiyama K, Kato N, Re S, Kinugasa K, Watanabe K, Takita R, Nogawa T, Hino T, Osada H, Sugita Y, Takahashi S, Nagano S Angew Chem Int Ed Engl. 2021 Jun 13. doi: 10.1002/anie.202106186. PMID:34121297<ref>PMID:34121297</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 7e5v" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Fujiyama K]] | + | [[Category: Pyrsx]] |
- | [[Category: Hino T]] | + | [[Category: Fujiyama, K]] |
- | [[Category: Kato N]] | + | [[Category: Hino, T]] |
- | [[Category: Kinugasa K]] | + | [[Category: Kato, N]] |
- | [[Category: Nagano S]] | + | [[Category: Kinugasa, K]] |
- | [[Category: Takahashi S]] | + | [[Category: Nagano, S]] |
+ | [[Category: Takahashi, S]] | ||
+ | [[Category: Biosynthetic protein]] | ||
+ | [[Category: Cyclase]] | ||
+ | [[Category: Diels alder]] | ||
+ | [[Category: Diels-alderase]] |
Revision as of 12:51, 13 October 2021
Crystal structure of Phm7 in complex with inhibitor
|
Categories: Large Structures | Pyrsx | Fujiyama, K | Hino, T | Kato, N | Kinugasa, K | Nagano, S | Takahashi, S | Biosynthetic protein | Cyclase | Diels alder | Diels-alderase